missing translation for 'onlineSavingsMsg'
Learn More

Piroxicam, MedChemExpress

Product Code. 16472109
Encompass_Preferred
Click to view available options
Quantity:
1 g
5 g
10 g
Unit Size:
10g
1g
5g
This item is not returnable. View return policy

Product Code. 16472109

Brand: Medchem Express HYB0253

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Piroxicam (CP-16171) is a non-steroidal anti-inflammatory drugs, acts as a COX inhibitor, with IC50s of 47, 25 μM for human monocyte COX-1 and COX-2, respectively.

Piroxicam (CP-16171) is a non-steroidal anti-inflammatory drugs, acts as a COX inhibitor, with IC50s of 47, 25 μM for human monocyte COX-1 and COX-2, respectively.

Specifications

Chemical Name or Material Piroxicam
CAS 36322-90-4
Color Light Yellow
Purity Grade Notes Research
Molecular Formula C15H13N3O4S
Quantity 1 g
Synonym CP-16171
Solubility Information DMSO : 50 mg/mL (150.90 mM; Need ultrasonic) ∣H2O : < 0.1 mg/mL (insoluble)
SMILES O=C(C1=C(O)C2=CC=CC=C2S(N1C)(=O)=O)NC3=NC=CC=C3
Molecular Weight (g/mol) 331.35
Formula Weight 331.35
Percent Purity 99.61%
Grade Research
Physical Form Solid
For Use With (Application) COVID-19-immunoregulation
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.